Your session is about to expire
← Back to Search
NightOwl for Sleep Apnea
N/A
Waitlist Available
Led By Jagdeep Bijwadia, MD MBA
Research Sponsored by Ectosense NV
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Subjects with an indication for an in-lab polysomnography
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 month.
Awards & highlights
Study Summary
This study is evaluating whether a new device may be able to detect sleep apnea.
Eligible Conditions
- Sleep Apnea
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1 month.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 month.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The Evaluation of the Level of Agreement (Classification Accuracy) Between Patient Categorization
Trial Design
1Treatment groups
Experimental Treatment
Group I: PSG and NightOwlExperimental Treatment1 Intervention
During the study, for each execution day, all patients that have been scheduled for a PSG will be presented with the informed consent form. All recruited patients shall be a part of the study during which they wear the NightOwl Sensor while undergoing the PSG exam.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
NightOwl
2019
N/A
~240
Find a Location
Who is running the clinical trial?
Ectosense NVLead Sponsor
6 Previous Clinical Trials
1,224 Total Patients Enrolled
3 Trials studying Sleep Apnea
1,056 Patients Enrolled for Sleep Apnea
Jagdeep Bijwadia, MD MBAPrincipal InvestigatorSleepMed RX
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger